GMP News - Inspections/Audits

27.03.19

US FDA Warning Letters for inadequate Batch Records

The U.S. FDA posted new Warning Letters to pharmaceutical companies which ignored basic GMP principles.

20.03.19

Current Q&A on the MRA EU-FDA

The EMA has published a new Questions and Answers (Q&A) document on the Mutual Recognition Agreement (MRA) between the EU and the FDA. Read more about the impact of the MRA on regulatory submissions and variations.

13.03.19

Warning Letter: FDA criticises Supplier Qualification

The full programme is part of a recent FDA Warning Letter, which the FDA sent to a manufacturer in the US only in February: Supplier Qualification, contract management, release procedure.

13.03.19

Switzerland now also uses EudraGMDP

Switzerland has begun to enter information on GMP inspections into the EMA database.

13.03.19

Is an Identity Test needed for the content of all Containers?

In a recent Warning Letter, FDA is criticising a Chinese company for their inappropriate identity testing.

20.02.19

EU-FDA MRA to be expanded

The scope of the EU-FDA Mutual Recognition Agreement (MRA) will be extended to veterinary medicinal products, human vaccines and plasma derivatives.

13.02.19

EU-FDA MRA: Soon all States on board

The MRA with the USA was supplemented by two further countries: Poland and Slovenia. However some are still missing.

23.01.19

Non-Compliance at Chinese Heparin Manufacturer

A Non-Compliance Report due to several GMP violations has been issued to a Chinese heparin manufacturer after an inspection conducted by the Italian Health Authority. This report is now available on the EMA website for Non-Compliance Reports.

19.12.18

Non-Compliance at Italian Sterile Manufacturer

In the course of an inspection conducted in October 2018, the Italian health authority discovered several GMP deviations in the areas of sterile manufacturing, packaging and QC testing at an Italian manufacturer. Read more details about the Non-Compliance Report which can now be found in EMA's inspection database.

11.12.18

Poor GMP/GDP Practice found in US Warehouse

In a warehouse in Arkansas, USA, the US Food and Drug Administration (FDA) found "alarming" insanitary conditions.

28.11.18

MRA: FDA accepts four new States

The US Food and Drug Administration (FDA) announced that it accepted four new states, which will now benefit from the EU-US Mutual Recognition Agreement MRA.

21.11.18

A global Approach to Classification of GMP Deficiencies?

PIC/S adopted a new Guidance on Classification of GMP Deficiencies. It supports the global harmonisation of the classification of GMP deficiencies.

14.11.18

Valsartan: New Inspection reveals significant GMP Violations

An inspection by EU inspectorates in collaboration with EDQM has revealed significant GMP violations at a Valsartan manufacturer's site.

02.10.18

Portugal now part of MRA with FDA

Portugal has been accepted by FDA and will now benefit from the EU-US Mutual Recognition Agreement for inspections.

26.09.18

How FDA will prioritise Inspections

The US FDA has published a so called internal Manual of Policies and Procedures (MAPP) describing how the agency will prioritise its pharmaceutical inspections.

Page 21 of 31

Recommended Event

Hamburg, Germany

26/27 June 2024

GMP SEARCH ENGINE

GMP News - Inspections/Audits

US FDA Warning Letters for inadequate Batch Records

Current Q&A on the MRA EU-FDA

Warning Letter: FDA criticises Supplier Qualification

Switzerland now also uses EudraGMDP

Is an Identity Test needed for the content of all Containers?

EU-FDA MRA to be expanded

EU-FDA MRA: Soon all States on board

Non-Compliance at Chinese Heparin Manufacturer

Non-Compliance at Italian Sterile Manufacturer

Poor GMP/GDP Practice found in US Warehouse

MRA: FDA accepts four new States

A global Approach to Classification of GMP Deficiencies?

Valsartan: New Inspection reveals significant GMP Violations

Portugal now part of MRA with FDA

How FDA will prioritise Inspections

Recommended Event

Dissolution Testing Development / Quality Control and in vivo Relevance

GMP News - Inspections/Audits

US FDA Warning Letters for inadequate Batch Records

Current Q&A on the MRA EU-FDA

Warning Letter: FDA criticises Supplier Qualification

Switzerland now also uses EudraGMDP

Is an Identity Test needed for the content of all Containers?

EU-FDA MRA to be expanded

EU-FDA MRA: Soon all States on board

Non-Compliance at Chinese Heparin Manufacturer

Non-Compliance at Italian Sterile Manufacturer

Poor GMP/GDP Practice found in US Warehouse

MRA: FDA accepts four new States

A global Approach to Classification of GMP Deficiencies?

Valsartan: New Inspection reveals significant GMP Violations

Portugal now part of MRA with FDA

How FDA will prioritise Inspections

Recommended Event

Dissolution Testing Development / Quality Control and in vivo Relevance

GMP Newsletter

GMP Conferences by Topics